Form 4: Quanterix CFO Equity Vesting and Tax Withholding
Statement of Changes in Beneficial Ownership
Quanterix CFO Vandana Sriram reported the vesting of restricted stock units and subsequent tax-related share withholding.
Summary
- Chief Financial Officer Vandana Sriram acquired 1,833 shares of common stock through the vesting of restricted stock units (RSUs) on May 15, 2026.
- A total of 548 shares were withheld by the company to satisfy tax obligations associated with the vesting, at a price of $2.75 per share.
- Following these transactions, the CFO holds a total of 29,998 shares of Quanterix common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative event, as it represents standard executive compensation activity rather than a change in company strategy or financial performance.
Positives
- The transaction reflects the standard vesting of equity compensation, aligning the interests of the CFO with long-term shareholder value.
Negatives
- The withholding of shares for tax purposes results in a minor reduction of the total potential equity stake held by the executive.
Risks
- None identified; this is a routine administrative filing regarding executive compensation.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a disclosure of executive equity transactions.
Industry Context
StockSavvy.ai notes that routine equity vesting disclosures are standard corporate governance practices for publicly traded biotechnology and life sciences firms like Quanterix, ensuring transparency in executive compensation.
Comparison to Industry Standards
- The use of RSU vesting schedules with monthly installments is consistent with standard executive compensation packages in the life sciences sector.
- Tax withholding at the time of vesting is a standard practice for U.S. public companies to satisfy statutory tax requirements.
Stakeholder Impact
- Minimal impact on shareholders as the transaction involves existing equity compensation plans.
Next Steps
- Continued monthly vesting of remaining RSU tranches as per the established schedule.
Key Dates
| Date | Description |
|---|---|
| 08/21/2023 | Original grant date of initial RSU tranche and execution of Power of Attorney. |
| 02/02/2024 | Grant date of second RSU tranche. |
| 02/04/2025 | Grant date of third RSU tranche. |
| 05/15/2026 | Vesting date of RSU tranches and transaction date. |
| 05/18/2026 | Filing date of the Form 4. |
Keywords
Quanterix, QTRX, Insider Trading, Form 4, Equity Compensation, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.